Assembly Biosciences (ASMB) Operating Expenses (2010 - 2026)

Assembly Biosciences' Operating Expenses history runs 17 years deep, the most recent figure standing at $19.6 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 1.15% year-over-year to $19.6 million; the TTM figure through Mar 2026 stood at $84.6 million (up 10.23% YoY), while the FY2025 annual figure was $84.4 million, up 14.18% from the prior year.
• Operating Expenses was $19.6 million for Q1 2026 at Assembly Biosciences, down from $22.7 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $24.6 million in Q2 2022 to a low of -$55.5 million in Q4 2023.
• Historically, Operating Expenses has averaged $15.8 million across 5 years, with a median of $19.6 million in 2026.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses sank 341.59% in 2023, then surged 134.03% in 2024.
• A 5-year view of Operating Expenses shows it stood at $23.0 million in 2022, then slumped by 341.59% to -$55.5 million in 2023, then soared by 134.03% to $18.9 million in 2024, then advanced by 20.02% to $22.7 million in 2025, then slipped by 13.62% to $19.6 million in 2026.
• The last three Operating Expenses figures came in at $19.6 million (Q1 2026), $22.7 million (Q4 2025), and $21.7 million (Q3 2025), per Business Quant data.